SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-310766
Filing Date
2020-12-04
Accepted
2020-12-04 17:12:58
Documents
2
Group Members
MARC A. SINGEROSAGE UNIVERSITY GP III, LLCROBERT S. ADELSONWILLIAM T. HARRINGTON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d96683dsc13ga.htm SC 13G/A 77449
2 EX-99.1 d96683dex991.htm EX-99.1 5049
  Complete submission text file 0001193125-20-310766.txt   84285
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91126 | Film No.: 201370635
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 MONUMENT ROAD BALA CYNWYD PA 19004
Business Address 50 MONUMENT ROAD BALA CYNWYD PA 19004 (484) 434-2255
Osage University Partners III, LP (Filed by) CIK: 0001743036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A